Advertisement

Topics

KIACTA - Biotech, Pharma and Life Science Channel

01:29 EST 24th January 2019 | BioPortfolio

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory conditions.

KIACTA™ is partenered with global private equity firm Auven Therapeutics (previously Celtic Therapeutics). Patients are currently being enrolled in a Phase III Confirmatory Study for KIACTA™. This pivotal study will be used to confirm the positive safety and efficacy results shown in the Phase II/III study previously conducted BELLUS Health.

PubMed Articles [0 Results]

None

News Articles [3 Associated News Articles listed on BioPortfolio]

BELLUS Health Inc BLU Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryBELLUS Health Inc BELLUS Health is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company's pipeline products include BLU5937 for chronic coug...

BELLUS Health Inc BLU Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryBELLUS Health Inc BELLUS Health is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company's pipeline products include BLU5937 for chronic coug...

BELLUS Health Inc BLU Financial and Strategic SWOT Analysis Review [Report Updated: 11072018] Prices from USD $125

BELLUS Health Inc BLU Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalD...

Companies [1 Associated Companies listed on BioPortfolio]

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

A Phase IIa Proof-of-Concept Study of NC-503 in Patients With Type II Diabetes

The main objectives of the current study are to establish the safety and clinical proof-of-concept of NC-503 in inadequately controlled patients with Type 2 diabetes and features of metabo...

Medical and Biotech [MESH] Definitions

None available.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...